Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.3K
Hardy-Weinberg Principle01:49

Hardy-Weinberg Principle

72.5K
Diploid organisms have two alleles of each gene, one from each parent, in their somatic cells. Therefore, each individual contributes two alleles to the gene pool of the population. The gene pool of a population is the sum of every allele of all genes within that population and has some degree of variation. Genetic variation is typically expressed as a relative frequency, which is the percentage of the total population that has a given allele, genotype or phenotype.
72.5K
Types of Selection01:46

Types of Selection

40.8K
Natural selection influences the frequencies of particular alleles and phenotypes within populations in several different ways. Primarily, natural selection can be directional, stabilizing, or disruptive. Directional selection favors one extreme trait and shifts the population towards that phenotype while selecting against individuals displaying alternate traits. Stabilizing selection favors an intermediate trait with a narrow range of variation. Deviation from the optimal phenotype towards an...
40.8K
Nondisjunction01:21

Nondisjunction

3.9K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn's disease pathogenesis.

Nature genetics·2026
Same author

Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

Nature cancer·2026
Same author

High-confidence structural predictions of extrachromosomal DNA with ecDNAInspector.

bioRxiv : the preprint server for biology·2026
Same author

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.

Cancer discovery·2026
Same author

Tissue-specific mutagenesis from endogenous guanine damage is suppressed by Polκ and DNA repair.

Nature communications·2025
Same author

JASPAR 2026: expansion of transcription factor binding profiles and integration of deep learning models.

Nucleic acids research·2025
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jul 28, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.4K

Evolución determinista y selección estricta durante la preneoplasia

Kasper Karlsson1,2,3,4, Moritz J Przybilla3,5, Eran Kotler2,3

  • 1Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Nature
|May 31, 2023
PubMed
Resumen
Este resumen es generado por máquina.

Al estudiar los primeros eventos de cáncer gástrico, los investigadores descubrieron que la inactivación del gen TP53 impulsa la progresión del cáncer. Esta investigación revela patrones predecibles en la evolución del tumor, lo que ayuda a las estrategias de detección y prevención tempranas.

Más Videos Relacionados

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia
08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

15.1K
Detecting Protein Subcellular Localization by Green Fluorescence Protein Tagging and 4',6-Diamidino-2-phenylindole Staining in Caenorhabditis elegans
09:36

Detecting Protein Subcellular Localization by Green Fluorescence Protein Tagging and 4',6-Diamidino-2-phenylindole Staining in Caenorhabditis elegans

Published on: July 30, 2018

9.6K

Videos de Experimentos Relacionados

Last Updated: Jul 28, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.4K
Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia
08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

15.1K
Detecting Protein Subcellular Localization by Green Fluorescence Protein Tagging and 4',6-Diamidino-2-phenylindole Staining in Caenorhabditis elegans
09:36

Detecting Protein Subcellular Localization by Green Fluorescence Protein Tagging and 4',6-Diamidino-2-phenylindole Staining in Caenorhabditis elegans

Published on: July 30, 2018

9.6K

Área de la Ciencia:

  • En el campo de la oncología
  • La genética
  • Biología molecular

Sus antecedentes:

  • Los eventos tempranos en la iniciación de tumores en humanos son poco conocidos, pero son cruciales para la detección y prevención de tumores malignos.
  • La inactivación bialélica de TP53 es un evento temprano común en el desarrollo del cáncer gástrico.

Objetivo del estudio:

  • Modelar la preneoplasia oculta mediante el estudio de la inactivación de la TP53 en los organoides gástricos humanos.
  • Establecer relaciones causales entre la lesión genética TP53 y los fenotipos resultantes utilizando la evolución experimental.

Principales métodos:

  • Se utilizaron organoides gástricos humanos con inactivación bialélica de la TP53.
  • Evolución experimental empleada durante dos años con múltiples cultivos derivados por clonación.
  • Se llevó a cabo la secuenciación longitudinal de una sola célula y el seguimiento del linaje de alto rendimiento con códigos de barras celulares expresados.

Principales resultados:

  • La pérdida de TP53 indujo una aneuploidía progresiva, incluyendo alteraciones en el número de copias y variantes estructurales comunes en los cánceres gástricos.
  • La secuenciación longitudinal de una sola célula mostró progresión hacia programas transcripcionales malignos en organoides con deficiencia de TP53.
  • El rastreo del linaje reveló dinámicas reproducibles de dominio de subclones y convergencia fenotípica.

Conclusiones:

  • La evolución experimental en organoides premalignados demuestra una selección estricta, una interferencia clonal y una convergencia fenotípica.
  • Estos hallazgos sugieren previsibilidad en las primeras etapas de la tumorigénesis.
  • El estudio implica restricciones evolutivas y barreras a la transformación maligna, con implicaciones para la detección temprana e interceptación de tumores agresivos.